Shares of Robinhood Markets, Inc. HOOD rose sharply in pre-market trading .
S&P Dow Jones Indices announced a sweeping update to its benchmarks late Friday, unveiling new additions to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600. Robinhood will replace Caesars Entertainment Inc. CZR in the S&P 500, effective prior to the open of trading on Monday, Sept. 22.
Robinhood shares jumped 7.4% to $108.77 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
Eightco Holdings Inc. OCTO shares gained 142.1% to $3.51 in pre-market trading. Gyrodyne, LLC GYRO rose 82.1% to $19.48 in pre-market trading. Forward Industries, Inc. FORD gained 78.8% to $29.29 in pre-market trading after gaining 10% on Friday. Pintec Technology Holdings Limited PT rose 62.1% to $1.54 in pre-market trading. PINTEC announced a private placement of Class A ordinary shares in exchange of ordinary shares of ZIITECH PTY LTD. CDT Equity Inc. CDT rose 45.7% to $1.72 n pre-market trading. Seres Therapeutics, Inc. MCRB gained 44.8% to $28.05 in pre-market trading. Microbot Medical Inc. MBOT jumped 27.3% to $4.66 in pre-market trading after gaining 9% on Friday. Acrivon Therapeutics, Inc. ACRV gained 27.8% to $1.70 in pre-market trading. Rapport Therapeutics, Inc. RAPP surged 26.3% to $18.13 in pre-market trading. Rapport Therapeutics will announce topline results for RAP-219 Phase 2a trial in focal onset seizures on Monday, Sept. 8.Losers
Citius Oncology, Inc. CTOR dipped 25% to $1.41 in pre-market trading. MEI Pharma, Inc. MEIP fell 19.3% to $3.42 in pre-market trading. CNFinance Holdings Limited CNF fell 18.8% to $3.78 in pre-market trading after jumping 94% on Friday. New Era Energy & Digital, Inc. NUAI shares dipped 17.3% to $0.3111 in pre-market trading after declining 7% on Friday. Summit Therapeutics Inc. SMMT declined 17% to $21.57 in pre-market trading after the company announced the updated overall survival results from the Global Phase 3 HARMONi clinical trial of Ivonescimab in EGFR-mutated non-squamous non-small cell lung cancer. Twin Vee Powercats Co. VEEE fell 15.3% to $2.40 in pre-market trading after jumping 46% on Friday. iSpecimen Inc. ISPC fell 15% to $0.7262 in pre-market trading. iSpecimen shares surged 27% on Friday after the company announced it advanced its $200 million Solana-based digital asset strategy. Sono Group N.V. SSM declined 15% to $12.30 in pre-market trading after dipping 34% on Friday. Sono Group announced Nasdaq uplisting approval. New Fortress Energy Inc. NFE dipped 12.5% to $2.14 in pre-market trading following second-quarter results. Verb Technology Company, Inc. TONX fell 11.9% to $9.45 in the pre-market trading.Now Read This:
T op 2 Health Care Stocks That May Plunge This MonthPhoto via Shutterstock
Loading... Loading... ACRV Acrivon Therapeutics Inc $1.69 27.1%Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Unlock RankingsEdge Rankings
Momentum 1.51Price Trend
Short Medium Long Overview CDT CDT Equity Inc $1.60 35.6% CNF CNFinance Holdings Ltd $3.60 -22.8% CTOR Citius Oncology Inc $1.41 -25.0% CZR Caesars Entertainment Inc $26.34 -% FORD Forward Industries Inc $28.06 71.6% GYRO Gyrodyne LLC $17.99 68.1% HOOD Robinhood Markets Inc $108.82 7.48% ISPC iSpecimen Inc $0.7202 -15.6% MBOT Microbot Medical Inc $4.68 27.9% MCRB Seres Therapeutics Inc $28.40 46.7% MEIP MEI Pharma Inc $3.38 -20.1% NFE New Fortress Energy Inc $2.13 -13.1% NUAI New Era Energy & Digital Inc $0.3200 -15.1% OCTO Eightco Holdings Inc $3.40 134.5% PT Pintec Technology Holdings Ltd $1.47 54.7% RAPP Rapport Therapeutics Inc $18.87 31.4% SMMT Summit Therapeutics Inc $21.48 -17.3% SSM Sono Group NV $12.34 -14.7% TONX TON Strategy Co $9.30 -13.2% VEEE Twin Vee PowerCats Co $2.41 -15.1% Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News Pre-Market Outlook Markets Movers Trading Ideas